In addition, Z. officinale (56, 57), L. barbarum (61), and P. vulgaris (102) have shown anti-inflammatory effects through MCP-1 reduction, supporting their role in managing DKD-related inflammation. This evidence concerns the gene CCL2 and diabetic kidney disease.